Retraction: Prevention of Emetic Episodes During Cesarean Delivery Performed Under Regional Anesthesia in Parturients (Curr Drug Saf, (2007) 2, 1, (25-32), 10.2174/157488607779315381);Prevention of emetic episodes during cesarean delivery performed under regional anesthesia in parturients

Current Drug Safety

Volumn 2, Issue 1, 2007, Pages 25-32

  Fujii, Yoshitaka ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antiemetics; Cesarean delivery; Complications; Nausea; Parturients; Vomiting

Indexed keywords

ANTIEMETIC AGENT; BENZAMIDE DERIVATIVE; BUTYROPHENONE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DEXAMETHASONE; DOLASETRON MESILATE; DROPERIDOL; FENTANYL; GLYCOPYRRONIUM BROMIDE; GRANISETRON; METOCLOPRAMIDE; MORPHINE; ONDANSETRON; PLACEBO; PROPOFOL; RAMOSETRON; SCOPOLAMINE; SEROTONIN ANTAGONIST; TROPISETRON;

ACUPRESSURE; ACUPUNCTURE; AGE; AKATHISIA; ANESTHESIOLOGICAL TECHNIQUES; ANTIEMETIC ACTIVITY; CESAREAN SECTION; CHEMORECEPTOR REFLEX; CHILDBIRTH; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DROWSINESS; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; DYSPHORIA; EPIDURAL ANESTHESIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HEART ARRHYTHMIA; HUMAN; INTERMETHOD COMPARISON; LONG QT SYNDROME; MEDICAL DECISION MAKING; MONOTHERAPY; MOTION SICKNESS; NONHUMAN; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PAIN; PRACTICE GUIDELINE; PREMEDICATION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REGIONAL ANESTHESIA; RESTLESSNESS; RETCHING; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; SEDATION; SIDE EFFECT; SMOKING HABIT; SPINAL ANESTHESIA; SURGEON; SURGICAL TECHNIQUE; XEROSTOMIA;

EID: 34248197172     PISSN: 15748863     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Erratum

References (72)

1. Ong BY, Cohen MM, Palahniuk RJ. Anesthesia for cesarean delivery-effect on neonates. Anesth Analg 1989; 68: 270-5.
2. Reynolds F. Epidural analgesia in obstetrics. Pros and cons for mother and baby. BMJ 1989; 299: 751-2.
3. Paech M. The use of combined spinal epidural anaesthesia for elective caesarean delivery is a waste of time and money (opposer). Int J Obstet Anesth 2001; 10: 32-4.
4. Collis RE, Baxandall ML, Shrikantharajah ID, et al. Combined spinal epidural (CSE) analgesia: technique, management and outcome of 300 mothers. Int J Obstet Anesth 1994; 3: 75-81.
5. Santos A, Datta S. Prophylactic use of droperidol for control of nausea and vomting during spinal anaesthesia for caesarean delivery. Anesth Analg 1984; 63: 85-7.
6. Lussos SA, Bader AM, Thornhill ML, et al. The antiemetic efficacy and safety of prophylactic metoclopramide for elective cesarean delivery delivery during spinal anesthesia. Reg Anesth 1992; 17: 126-30
7. Borgeat A, Ekatodramis G, Schenker CA. Postoperative nausea and vomiting in regional anesthesia. A review. Anesthesiology 2003; 98: 530-47.
8. Abouleish EI, Rashid S, Haque S, et al. Ondansetron versus placebo for the control of nausea and vomiting during caesarean delivery under spinal anaesthesia. Anaesthesia 1999; 54: 479-82.
9. Mandell GL, Dewan DM, Howard G, Floyd HM. The effectiveness of low dose droperidol in controlling nausea and vomiting during epidural anesthesia for cesarean section. Int J Obstet Anest 1992; 1: 65-8.
10. Fujii Y, Tanaka H, Toyooka H. Prevention of nausea and vomiting with granisetron, droperidol and metoclopramide during and after spinal anaesthesia for caesarean section: a randomized, doubleblind, placebo-controlled trial. Acta Anaesthesiol Scand 1998; 42 921-5.
11. Chestnut DH, Vandewalker GE, Owen CL, et al. Administration of metoclopramide for prevention of nausea and vomiting during epidural anesthesia for elective cesarean section. Anesthesiology 1987; 66: 563-6.
12. Chestnut DH, Owen CL, Geiger M, et al. Metoclopramide versus droperidol for prevention of nausea and vomiting during epidural anesthesia for cesarean section. South Med J 1989; 82: 1224-7.
13. Ure D, James KS, McNeill M, et al. Glycopyrrolate reduces nausea during spinal anaesthesia for Ceasarean section without affacting neonatal outcome. Br J Anaesth 1999; 82: 277-9.
14. Kotelko DM, Rottman RL, Wright WC, et al. Transdermal scoplamine decreases nausea and vomiting following cesarean section in parturients receiving epidural morphine. Anesthesiology 1989; 71: 675-8.
15. Numazaki M, Fujii Y. Subhypnotic dose of propofol for the prevention of nausea and vomiting during spinal anaesthesia for caesarean section. Anaesth Intensive Care 2000; 28: 262-5.
16. Fujii Y, Numazaki M. Dose-range effects of propofol for reducing emetic symptoms during cesarean delivery. Obstet Gynecol 2002; 99: 75-9.
17. Numazaki M, Fujii Y. Reduction of emetic symptoms during cesarean delivery with antiemetics: propofol at subhypnotic dose versus traditional antiemetics. J Clin Anesth 2003; 15: 423-7.
18. Shi J-J, Wang Y-P, Sun W-Z, et al. The effect of low dose propofol for prevention of nausea and vomiting during spinal anesthesia for cesarean section. Acta Anaesthesiol Sin 1994; 32: 95-8.
19. Tzeng JI, Wang JJ, Ho ST, et al. Dexamethasone for prophylaxis of nausea and vomiting after epidural morphine for post-Caesarean section analgesia. Comparison of droperidol and saline. Br J Anaesth 2000; 85: 865-8.
20. Wang JJ, Ho ST, Wong CS, et al. Dexamethsone prophylaxis of nausea and vomiting after epidural morphine for post-Cesarean analgesia. Can J Anaesth 2001; 48: 185-90.
21. Nortcliffe SA, Shah J, Buggy DJ. Prevention of postoperative nausea and vomiting after spinal morphine for Caesarean section: comparison of cyclizine, dexamethasone and placebo. Br J Anaesth 2003; 90: 665-70.
22. Pan PH, Moore CH. Comparing the efficacy of prophylactic metoclopramide, ondansetron, and placebo in cesarean section patients given epidural anesthesia. J Clin Anesth 2001; 13: 430-5.
23. Pan PH, Moore CH. Intraoperative antiemetic efficacy of prophylactic ondansetron versus droperidol for cesarean section patients under epidural anesthesia. Anesth Analg 1996; 83: 982-6.
24. Yazigi A, Chalhoub V, Madi-Jebara S, et al. Prophylactic ondansetron is effective in the treatment of nausea and vomiting but not on pruritus after casarean delivery with intrathecal sufentanil-morphine. J Clin Anesth 2002; 14: 183-6.
25. Fujii Y, Tanaka H, Toyooka H. Granisetron prevents nausea and vomiting during spinal anaesthesia for caesarean section. Acta Anaesthesiol Scand 1998; 42: 312-5.
26. Fujii Y, Tanaka H, Toyooka H. Prevention of nausea and vomiting with granisetron, droperidol and metoclopramide during and after spinal anaesthesia for caesarean section: a randomized, double-blind, placebo-controlled trial. Acta Anaesthesiol Scand 1998; 42: 921-5.
27. Fujii Y, Saitoh Y, Tnaka H, Toyooka H. Granisetron/dexamethasone combination for reducing nausea and vomiting during and after spinal anesthesia for cesarean section. Anesth Analg 1999; 88: 1346-50.
28. Fujii Y, Numazaki M. Randomized, double-blind comparison of subhypnotic-dose propofol alone and combined with dexamethasone for emesis in parturients undergoing cesarean delivery. Clin Ther 2004; 26: 1286-91.
29. Kocamanoglu IS, Baris S, Karakaya D, et al. Effects of granisetron with droperidol or dexamethasone on preventing postoperative nausea and vomiting after general anesthesia for cesarean section. Methods Find Exp Clin Pharmacol 2005; 27: 489-93.
30. Harmon D, Ryan M, Kelly A, et al. Acupressure and prevention of nausea and vomiting during and after spinal anaesthesia for Caesarean section. Br J Anaesth 2000; 84: 463-7.
31. Stein DJ, Birnbach DJ, Danzer BI, et al. Acupressure versus intravenous metoclopramide to prevent nausea and vomiting during spinal anesthesia for casarean section. Anesth Analg 1997; 84: 342-5.
32. Ho C-M, Tsai H-J, Chan K-H, et al. P6 acupressure does not prevent emesis during spinal anesthesia for cesarean delivery. Anesth Analg 2006; 102: 900-3.
33. Datta S, Alper MH, Ostheimer GW, et al. Method of ephedrine administration and nausea and hypotension during spinal anesthesia for cesarean delivery. Anesthesiology 1982; 56: 68-70.
34. Patra CK, Badola RP, Bhargava KP. A study of factors concerned in emesis during spinal anaesthesia. Br J Anaesth 1972; 44: 1208-11.
35. Rout CC, Rocke DA. Prevention of hypotension following spinal anesthesia for cesarean delivery. Int Anesthesiol Clin 1994; 32: 117-35.
36. Ngan Kee WD, Khaw KS, Lee BB, et al. A dose-response study of prophylactic intravenous ephedrine for the prevention of hypotension during spinal anesthesia for cesarean deliverly. Anesth Analg 2000; 90: 1390-5.
37. Watcha MF, White PF. Postoperative nausea and vomoting: its etiology, treatment, and prevention. Anesthesiology 1992; 77: 162-84.
38. Belleville WJ, Irwin DJ, Howland WS. Postoperative nausea and vomiting IV: factors related to postoperative nausea and vomiting. Anesthesiology 1960; 21: 186-93.
39. Beattie WS, Lindblad T, Buckley DN, et al. The incidence of post-operative nausea and vomiting undergoing laparoscopy is influenced by the day of menstrual cycle. Can J Anaesth 1991; 38: 298-302.
40. Hough MB, Sweeney BP. The influence of smoking on postoperative nausea and vomiting. Anaesthesia 1998; 53: 932-3.
41. Sweeney BP. Why does smoking protect against PONV? Br J Anaesth 2002; 89: 810-3.
42. Smessaert A, Schehr CA, Artusio JF, Jr. Nausea and vomiting in the immediate postoperative period. JAMA 1959; 170: 2072-6.
43. Alahuhta S, Kangas-Saarela T, Hollmen AI, et al. Visceral pain during caesaren delivery under spinal and epidural anaesthesia with bupivacaine. Acta Anaesthesiol Scand 1990; 34: 95-8.
44. Ishiyama T, Yamaguchi T, Kashimoto S. Effects of epidural fentanyl and intravenous flurbiprofen for visceral pain during cesarean delivery under spinal anesthesia. J Anesth 2001; 15: 69-73.
45. Dahl JB, Jeppesen IS, Jorgensen H, et al. Intraoperative and post-operative analgesic efficacy and adverse effects of intrathecal opioids in patients undergoing cesarean section with spinal anesthesia: a qualitative and quantitave systematic review of randomnized controlled trials. Anesthesiology 1999; 91: 1919-27.
46. Naulty JS, Datta S, Ostheimer GW, et al. Epidural fentanyl for postcesarean delivery pain management. Anesthesiology 1985; 63: 694-8.
47. Palmer CM, Nogami WN, Van Maren G, et al. Postcesarean epidural morphine: a dose-responese study. Anesth Analg 2000; 90: 887-91.
48. Jenkins JC, Lahay D. Central mechanism of vomiting related to catecholamine response. Anaesthetic implication. Can Anaesth Soc J 1971; 18: 434-41.
49. Chaney MA. Side effects of intrathecal and epidural opioids. Can J Anaesth 1995; 42: 891-903.
50. Loeser EA, Bennet G, Stanley TH, et al. Comparison of droperidol, haloperidol and prochlorperazine as postoperative antimetics. Can Anaesth Soc J 1979; 26: 125-7.
51. Harrington RA, Hamilton CW, Brogden RN, et al. Metoclopramide: an update review of its pharmacological properties and clinical use. Drugs 1983; 25: 451-94.
52. McCarthy BG, Peroutka SJ. Differentiation of the muscarinic cholinergic receptor subtypes in human cortex and pons. Implications for anti-motion sickness therapy. Aviat Space Environ Med 1988; 59: 63-6.
53. McCormick C. FDA alert. Current FDA report on droperidol status and basis for 'black box' warning. Am Soc Anesthesiologists Newsletter 2002; 66: 19-20.
54. Habib AS, Gan TJ. Food and Drug Administration black box warning on the perioperative use of droperidol: a review of the cases. Anesth Analg 2003; 96: 1377-9.
55. Smith I, White PF, Nathanson M, et al. Propofol: an updata on its clinical use. Anesthesiology 1994; 81: 1005-43.
56. Borgeat A, Wilder-Smith OHG, Saiah M, et al. Subhypnotic doses of propofol possess direct antiemetic properties. Anesth Analg 1992; 74:539-41.
57. Ostman PL, Faure E, Glosten B, et al. Is the antiemetic effect of the emulsion formulation of propofol due to the lipid emulsion? Anesth Analg 1990; 71: 536-40.
58. Cechetto DF, Diab T, Gibson CJ, et al. The effects of propofol in the area postrema of rats. Anesth Analg 2001; 92: 934-42.
59. Henzi I, Walder B, Tramer MR, et al. Dexamethasone for prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 2000; 99: 186-94.
60. Wang JJ, Ho ST, Liu YH, et al. Dexamethasone reduces nausea and vomiting after laparoscopic cholecystectomy. Br J Anaesth 1999; 83: 772-5.
61. Bunce KT, Tyers MB. The role of 5-HT in postoperative nausea and vomiting. Br J Anaesth 1992; 69: 60S-62S.
62. Alon E, Kocian R, Nett PC, et al. Tropisetron for the prevention of postoperative nausea and vomiting in women undergoing gynecologic surgery. Anesth Analg 1996; 82: 338-41.
63. Gracyzk SG, McKenzie R, Kaller S, et al. Intravenous dolasetron for the prevention of postoperative nausea and vomiting after outpatient laparoscopic gynecologic surgery. Anesth Analg 1997; 84: 325-30.
64. Fujii Y, Saitoh Y, Tanaka H, Toyooka H. Romesetron for preventing postoperative nausea and vomiting in women undergoing gynecological surgery. Anesth Analg 2000; 90: 472-5.
65. Tolan MM, Fuhrman TM, Tsueda K, et al. Perioperative extrapyramidal reactions associated with ondansetron. Anesthesiology 1999; 90: 340-1.
66. Sprung J, Choudhry FM, Hall BA. Extrapyramidal reactions to ondansetron: cross-reactivity between ondansetron and prochlorperazine ? Anesth Analg 2003; 96:1374-6.
67. Rowbotham DJ. Current management of postoperative nausea and vomiting. Br J Anaesth 1992; 69: 46S-59S.
68. Young S. Mechanism of decline in rat brain 5-hydroxytryptamine after induction of liver tryptophan pyrolase by hydrocortisone: role of tryptophan catabolism and kynureine synthesis. Br J Pharmacol 1981; 74: 695-700.
69. Frederikson M, Mursti T, Furst C, et al. Nausea in cancer chemotheraphy is inversely related to urinary cortisol excretion. Br J Cancer 1992; 65: 779-80.
70. Sager S. The current role of anti-emetic drugs in oncology: a recent revolution in patient symptom control. Cancer Treat Rev 1991; 18: 95-135.
71. Lee A, Done ML. The use of nonpharmacologic techniques to prevent postoperative nausea and vomiting: a meta-analysis. Anesth Analg 1999; 88: 1362-9.
72. Al-Sadi M, Newman B, Julious SA. Acupuncure in the prevention of postoperative nausea and vomiting. Anaesthesia 1997; 52: 658-61.